BRD4 and neoplasm: In addition to possible clonal heterogeneity of the PIK3CA gene mutation, the authors showed that this intra-tumour heterogeneity in glycolysis is further driven by bromodomain-containing protein 4 (BRD4) epigenetic remodelling and cell density [60].